162 related articles for article (PubMed ID: 9425932)
1. Pharmacological expression in rat hepatocytes of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cyclic adenosine monophosphate response elements.
Suzuki M; Singh RN; Crystal RG
Hepatology; 1998 Jan; 27(1):160-5. PubMed ID: 9425932
[TBL] [Abstract][Full Text] [Related]
2. Regulatable promoters for use in gene therapy applications: modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP.
Suzuki M; Singh RN; Crystal RG
Hum Gene Ther; 1996 Oct; 7(15):1883-93. PubMed ID: 8894680
[TBL] [Abstract][Full Text] [Related]
3. CART gene promoter transcription is regulated by a cyclic adenosine monophosphate response element.
Barrett P; Davidson J; Morgan P
Obes Res; 2002 Dec; 10(12):1291-8. PubMed ID: 12490674
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action.
Christ B; Nath A; Jungermann K
Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454
[TBL] [Abstract][Full Text] [Related]
5. Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl- secretion.
Suzuki M; Singh RN; Crystal RG
Gene Ther; 1997 Nov; 4(11):1195-201. PubMed ID: 9425443
[TBL] [Abstract][Full Text] [Related]
6. A new inducible adenoviral expression system that responds to inflammatory stimuli in vivo.
Cai G; Nie X; Guo P; Guan Z; Zhang J; Shen Q
J Gene Med; 2006 Dec; 8(12):1369-78. PubMed ID: 17133340
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.
Arita E; Kondoh M; Isoda K; Nishimori H; Yoshida T; Mizuguchi H; Yagi K
Eur J Pharm Biopharm; 2008 Sep; 70(1):1-6. PubMed ID: 18468873
[TBL] [Abstract][Full Text] [Related]
8. Heart muscle-specific gene expression using replication defective recombinant adenovirus.
Rothmann T; Katus HA; Hartong R; Perricaudet M; Franz WM
Gene Ther; 1996 Oct; 3(10):919-26. PubMed ID: 8908506
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
10. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
11. Regulation by glucagon (cAMP) and insulin of the promoter of the human phosphoenolpyruvate carboxykinase gene (cytosolic) in cultured rat hepatocytes and in human hepatoblastoma cells.
Rucktäschel AK; Granner DK; Christ B
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):211-7. PubMed ID: 11062075
[TBL] [Abstract][Full Text] [Related]
12. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated gene transfer during initial organogenesis in the mammalian embryo is promoter-dependent and tissue-specific.
Baldwin HS; Mickanin C; Buck C
Gene Ther; 1997 Nov; 4(11):1142-9. PubMed ID: 9425436
[TBL] [Abstract][Full Text] [Related]
14. Identification of an oxygen-responsive element in the 5'-flanking sequence of the rat cytosolic phosphoenolpyruvate carboxykinase-1 gene, modulating its glucagon-dependent activation.
Bratke J; Kietzmann T; Jungermann K
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):563-9. PubMed ID: 10215594
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT
Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer in the midgestation fetal mouse.
Lipshutz GS; Flebbe-Rehwaldt L; Gaensler KM
J Surg Res; 1999 Jun; 84(2):150-6. PubMed ID: 10357912
[TBL] [Abstract][Full Text] [Related]
18. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
20. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
Adachi Y; Reynolds PN; Yamamoto M; Grizzle WE; Overturf K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2000 Aug; 60(16):4305-10. PubMed ID: 10969765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
